Erythroxylum rotundifolium
Erythroxylum rotundifolium · Accepted scientific name
Scientific literature: Very Sparse (0 studies) · ★☆☆☆☆
Erythroxylum rotundifolium is a unique botanical species known for its diverse range of pharmacological activities. Derived primarily from the plant's stem, its chemical constituents offer significant therapeutic potential. Research indicates that it possesses anesthetic, anorexic, antiarrhythmic, and antibacterial properties. Notably, the plant shows promise in addressing complex medical challenges such as multidrug resistance. Understanding these bioactive capabilities is essential for advancing natural medicine and drug development.
- Synonyms
- Erythroxylum Pringlei · Erythroxylum Sessiliflorum · 10 more
- Common names
- Not available
- Family
- Erythroxylaceae
- Distribution
- Asia-Temperate
- Plant Parts
- Stem
Classification
Common Names
Erythroxylum rotundifolium is a plant recognized by a diverse array of local names across different geographic regions. In various areas, it is commonly referred to as Arabillo or Arabillo doce. The species also carries the name Brisselet within the Virgin Islands. Depending on the specific locale, it may be known as Careicillo by local inhabitants. Finally, in the Dominican Republic, this plant is frequently called Cargagua.
Sources: Catalogue of Life (COL)
Synonyms
Erythroxylum rotundifolium is a botanical species characterized by a complex history of taxonomic classifications. Throughout various scientific studies, several names have been formally identified as synonyms for this plant. These include the designations Erythroxylum brevipes var. spinescens and Erythroxylum compactum. Additionally, the species has been referred to in botanical literature as Erythroxylum fiscalense and Erythroxylum pallidum. Finally, the name Erythroxylum pringlei also serves as a recognized synonym within its taxonomic framework.
Sources: The World Checklist of Vascular Plants (WCVP)
Taxonomy
Erythroxylum rotundifolium belongs to the vast biological kingdom Plantae. Within this diverse kingdom, the species is classified under the class Equisetopsida. It further falls into the order Malpighiales, showcasing its specific evolutionary lineage. As a member of the Erythroxylaceae family, it shares distinct botanical characteristics with its relatives. Finally, this plant is identified by its specific genus, Erythroxylum.
| Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Malpighiales |
| Family | Erythroxylaceae |
| Genus | Erythroxylum |
Sources: The World Checklist of Vascular Plants (WCVP)
Distribution
Geographic Regions
Erythroxylum rotundifolium maintains a wide-reaching presence throughout Northern America and several key regions of Mexico. Its distribution spans extensively across the Mexican landscape, covering the Central and Gulf territories. The plant is also commonly found throughout the Northeast and Southeast portions of the country. Additionally, its range extends into the Southwest, showcasing its adaptability to diverse environments. This broad geographical spread highlights the robust nature of the species across the continent.
Sources: The World Checklist of Vascular Plants (WCVP)
Identification
Morphology
Erythroxylum rotundifolium is a self-supporting plant that exhibits a distinct tree-like growth form. This species typically reaches a modest height, though its stature can vary depending on environmental conditions. While many specimens stay relatively compact, the plant can reach a maximum height of 6 m. In optimal growing circumstances, it is capable of extending further to a maximum height of 9 m.
Sources: Global Inventory of Floras and Traits (GIFT)
Biological Activities
Compounds
Conditions
Erythroxylum rotundifolium contains tropane alkaloid esters in its stems that possess the ability to reverse multidrug resistance. Specifically, these alkaloids demonstrate significant activity against multidrug-resistant oral epidermoid carcinoma (KB-V1) cells when they are incubated with vinblastine. Research indicates that certain compounds from the plant, such as the new ester 2 and known esters 4, 5, and 6, are particularly effective in this role. This reversal of the multidrug-resistance phenotype is presumably achieved through the alkaloids' interaction with P-glycoprotein. Consequently, the chemical constituents of Erythroxylum rotundifolium serve as potent agents for treating resistant cancer cell lines.
Preparations
Parts used
Erythroxylum rotundifolium serves as a significant source of bioactive compounds found specifically within its stems. Recent scientific investigations have successfully isolated six distinct tropane alkaloid esters from these plant parts. Among these, several new structures were identified through advanced spectroscopic techniques. These alkaloids have demonstrated a remarkable ability to reverse multidrug resistance in certain human cancer cell lines. Specifically, these compounds appear to combat resistance by interacting with P-glycoprotein, offering potential implications for future oncology treatments.